Oxford spinout Alethio raises $90M Series A co-led by Sofinnova and RA Capital to take ET antibody ATX-011 into the clinic.
Kamau Therapeutics shares early data on nula-cel 2.0 for sickle cell disease; 3 patients show no pain crises or transfusion ...
Biotech pessimism about China more than doubles in Q3 BPSI, making it biopharma’s No. 2 worry, while Big Pharma stays net ...
Sanofi drops SAR448272, a STAT6 degrader developed with Nurix Therapeutics, after Phase 1 discontinuation. Nurix shares fell ...
CVS Health (Aetna, Caremark, Oak Street) and CVS Pharmacy. CEO David Joyner leads health unit; Prem Shah leads pharmacy.
J&J’s trispecific ramantamig shows 100% ORR in newly diagnosed myeloma, Tibsovo hits EFS in frontline AML, Calquence combo ...
Spyre drops SPY072 for rheumatic diseases after SKYWAY trial failures; Ideaya halts darovasertib UM trial; United ...
Endpoints’ Drew Armstrong and Max Bayer join policy expert Nick Shipley live Wednesday to break down what the US midterms ...
Pfizer CEO Albert Bourla says Trump’s MFN pricing deals will hold through the end of the term, even if Democrats win Congress.
Minghui Pharmaceutical will get $110 million upfront and up to $330 million in additional biobucks from Tokyo's ASKA ...
Novo raises 2026 outlook to flat sales as the Wegovy pill outsells Lilly’s Foundayo; CFO Knudsen hands over to Galderma’s ...
Marty Makary resigned as FDA commissioner on Tuesday after a turbulent tenure at the head of the agency. Makary was scheduled to sit down with senior reporter Max Bayer this week at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results